Advanced search
Publication Cover
Acta Oncologica Volume 47, 2008 - Issue 4
Journal homepage
3,133
Views
222
CrossRef citations to date
0
Altmetric
Original Article

The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise

Susanne Møller Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, DenmarkCorrespondence[email protected]
,
Maj-Britt Jensen Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark
,
Bent Ejlertsen Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
,
Karsten D. Bjerre Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark
,
Martin Larsen Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark
,
Hanne B. Hansen Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark
,
Peer Christiansen Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark; Unit of Breast and Endocrine Surgery, Aarhus University Hospital, Aarhus Sygehus, Denmark
&
Henning T. Mouridsen Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
 show all
Pages 506-524 | Received 10 Mar 2008, Published online: 08 Jul 2009

Figures & data

Table I.  Definition of low-risk groups in DBCG programmes.

Table II.  Adjuvant systemic therapy in high-risk patients in the DBCG programmes.

Figure 1.  Recruitment of patients to the DBCG programmes 1977–2006.

Figure 1.  Recruitment of patients to the DBCG programmes 1977–2006.

Table III.  Number of patients diagnosed with invasive breast cancer in the DBCG programmes, 1977–2006.

Table IV.  All patients diagnosed with invasive breast cancer in the DBCG database 1977–2006.

Table V.  Patients < 70 years with invasive breast cancer enrolled in the DBCG programmes, 1977–2006.

Figure 2.  Number of patients according to time, registered to DBCG, the Danish Cancer Registry (CR) and the National Pathology Registry (NPR).

Figure 2.  Number of patients according to time, registered to DBCG, the Danish Cancer Registry (CR) and the National Pathology Registry (NPR).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related Research Data

MyHealth: specialist nurse-led follow-up in breast cancer. A randomized controlled trial – development and feasibility
Source: Taylor & Francis
Mortality and recurrence rates among systemically untreated high risk breast cancer patients included in the DBCG 77 trials.
Source: Taylor & Francis
Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study
Source: Oxford University Press (OUP)
Validity of Danish Breast Cancer Group (DBCG) registry data used in the predictors of breast cancer recurrence (ProBeCaRe) premenopausal breast cancer cohort study
Source: (:unav)
Personality as a predictor of well-being in a randomized trial of a mindfulness-based stress reduction of Danish women with breast cancer
Source: Informa UK Limited
Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaboration.
Source: Informa UK Limited
Influence of comorbidity on the effect of adjuvant treatment and age in patients with early-stage breast cancer.
Source: Springer Science and Business Media LLC
Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990–2008
Source: Springer Science and Business Media LLC
Male breast cancer: a nation-wide population-based comparison with female breast cancer
Source: Informa UK Limited
Exposure to traffic noise and breast cancer
Source: Wiley
Unmet needs of women with breast cancer during and after primary treatment: A prospective study in Denmark
Source: Informa UK Limited
Opioids and Breast Cancer Recurrence
Source: Wiley
Long-term follow-up of late morbidity, cosmetic outcome and body image after breast conserving therapy. A study from the Danish Breast Cancer Cooperative Group (DBCG)
Source: Informa UK Limited
17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence: a Danish population-based study.
Source: Taylor & Francis
Changes in body mass index and alcohol and tobacco consumption among breast cancer survivors and cancer-free women: a prospective study in the Danish Diet, Cancer and Health Cohort.
Source: Informa UK Limited
Axillary lymph node dissection in breast cancer patients after sentinel node biopsy .
Source: Informa UK Limited
Accuracy of the Danish ‘distress thermometer’
Source: Wiley
Factors correlated with fatigue in breast cancer survivors undergoing a rehabilitation course, Denmark, 2002–2005
Source: Wiley
Quantitative analysis of the anti-proliferative activity of combinations of selected iron-chelating agents and clinically used anti-neoplastic drugs.
Source: Public Library of Science (PLoS)

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.